Wells Fargo Maintains Equal-Weight on RXO, Raises Price Target to $30

Wells Fargo analyst Christian Wetherbee has maintained an Equal-Weight rating on RXO (NYSE: RXO) and raised the price target from $23 to $30. This adjustment reflects a positive outlook on the company's performance.